Rang	Name	Position
1	Mr. Todd C. Davis Ph.D.	CEO & Director
2	Mr. Octavio Espinoza	Chief Financial Officer
3	Mr. Andrew T. Reardon J.D.	Chief Legal Officer & Secretary
4	Mr. Paul J. Hadden	Senior Vice President of Investments & Business Development
5	Ms. Melanie J. Herman CPA	Executive Director of Investor Relations and Financial Planning & Analysis
6	Ms. Marjorie Fackovec	Head of People Operations
7	Dr. Keith Marschke Ph.D.	Senior Vice President of Biology & Scientific Affairs
8	Dr. Vincent D. Antle Ph.D.	Senior Vice President of Technical Operations & QA - Capitsol
9	Dr. Karen R. Reeves M.D.	Senior VP of Investments & Head of Clinical Strategy
10	Mr. Richard B. Baxter	Senior VP of Investment Operations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	14,86%	0,84 Mrd. USD
2	Vanguard Portfolio Management, LLC	5,52%	0,31 Mrd. USD
3	HHG PLC	5,07%	0,29 Mrd. USD
4	Vanguard Capital Management, LLC	4,25%	0,24 Mrd. USD
5	Amvescap Plc.	4,13%	0,23 Mrd. USD
6	State Street Corp	3,91%	0,22 Mrd. USD
7	Congress Asset Management Company, LLP	3,31%	0,19 Mrd. USD
8	FMR Inc	2,99%	0,17 Mrd. USD
9	Delaware Management Holdings Inc	2,88%	0,16 Mrd. USD
10	Franklin Templeton Inc	2,88%	0,16 Mrd. USD
11	Geode Capital Management, LLC	2,80%	0,16 Mrd. USD
12	Chicago Capital LLC	2,78%	0,16 Mrd. USD
13	Stephens Inv Mgmt Group LLC	2,39%	0,14 Mrd. USD
14	Dimensional Fund Advisors, Inc.	2,15%	0,12 Mrd. USD
15	Massachusetts Financial Services Company	2,06%	0,12 Mrd. USD
16	The Goldman Sachs Group Inc	1,91%	0,11 Mrd. USD
17	Deutsche Bank AG	1,54%	0,09 Mrd. USD
18	Loomis, Sayles & Company LP	1,46%	0,08 Mrd. USD
19	Rice Hall James & Associates, LLC	1,35%	0,08 Mrd. USD
20	Ranger Investment Management LP	1,29%	0,07 Mrd. USD